ZQR-29139-90749
2 vaccinations
4 coded responses
5 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 775 / TX
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-08
Registered in v-safe
-
2021-03-08
Dose 1 — Pfizer-BioNTech
-
2021-03-08
Survey response — day 0, dose 1MedDRA: Nervousness — Feeling: Poor · Site: Pain · Fever · Chills, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Slightly shaky. Also, normal temp is 97.4 degrees F. 2 degree increase.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-29
Dose 2 — Pfizer-BioNTech
-
2021-03-29
Survey response — day 0, dose 2MedDRA: Body temperature increased — Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Almost 2 degree increase in temp.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-02
Survey response — 6 months, dose 2MedDRA: Cough, Fatigue, Productive cough, Secretion discharge, Sputum discoloured — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Increased coughing Increased mucous production/phlegm when coughing, sometimes greenish-brown in colorIncreased bouts of fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-03-29
Survey response — 12 months, dose 2MedDRA: Asthma, Body temperature increased, Bronchitis, Cough, Lethargy, Office visit, Pre-existing disease, SARS-CoV-2 test positive, Secretion discharge, Sinusitis, Sputum discoloured — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Bronchitis and sinusitis following a positive Covid result. Since positive: Increased use of rescue inhaler and nebulizer for moderate asthma, Lethargic, Deep chest cough, Discolored mucus when coughing/blowing nose, Low grade fever (99.0-99.7) · Healthcare visit (other): PulmonologistMedDRA releases: 2024-11 · check-in free text available
-
2022-03-29
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-30
-
2022-03-30
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Pfizer-BioNTech | |
| 2 | 2021-03-29 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-29 | Successful 2022-03-30 |
Participant prefers to complete VAERS report online |
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): Slightly shaky. Also, normal temp is 97.4 degrees F. 2 degree increase.
Release 6 — day 0, dose 2
Systemic reaction (other): Almost 2 degree increase in temp.
Release 9 — 6 months, dose 2
Symptoms: Increased coughing Increased mucous production/phlegm when coughing, sometimes greenish-brown in colorIncreased bouts of fatigue
Release 11 — 12 months, dose 2
Symptoms: Bronchitis and sinusitis following a positive Covid result. Since positive: Increased use of rescue inhaler and nebulizer for moderate asthma, Lethargic, Deep chest cough, Discolored mucus when coughing/blowing nose, Low grade fever (99.0-99.7)
Healthcare visit (other): Pulmonologist
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Asthma | · | · | ✓ |
| SD | Body temperature increased | · | · | ✓ |
| SD | Bronchitis | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Lethargy | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Secretion discharge | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Sputum discoloured | · | · | ✓ |
| SRO | Body temperature increased | ✓ | ✓ | ✓ |
| SRO | Nervousness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release